Year: 2022

Maravai LifeSciences and Recently-Appointed CEO Trey Martin Vigorously Defending Against Suit SAN DIEGO, Calif., Oct. 19, 2022 (GLOBE NEWSWIRE) — Executive Chairman and former CEO of Maravai LifeSciences, Inc. (NASDAQ: MRVI) Carl Hull, has been reinstated as CEO of the company on an interim basis. Three subsidiaries of Danaher Corporation, two of which previously employed recently-appointed Maravai CEO William “Trey” Martin, III, have filed a lawsuit against Martin and Maravai in the Delaware Court of Chancery alleging that Martin is in breach of a noncompetition agreement. On October 18, 2022, the Court issued a temporary restraining order against Martin prohibiting him from working for Maravai pending a preliminary injunction hearing that is expected to occur later this year.   “We have complete confidence in Trey and are appalled...

NEW YORK, NY, Oct. 19, 2022 (GLOBE NEWSWIRE) — Saratoga Investment Corp. (the “Company”) (NYSE: SAR) announced the commencement of a registered public offering of unsecured notes (the “Notes”).  The Company also announced that it has received an investment grade rating of “BBB+” from Egan-Jones Ratings Company, an independent, unaffiliated rating agency. Egan-Jones is a Nationally Recognized Statistical Rating Organization (NRSRO) and is recognized by the National Association of Insurance Commissioners (NAIC) as a Credit Rating Provider (CRP). Egan-Jones is also certified by the European Securities and Markets Authority (ESMA). The Notes are expected to be listed on the New York Stock Exchange and to trade thereon within 30 days of the original issue date under the trading symbol “SAJ”. Ladenburg Thalmann & Co. Inc. and Oppenheimer &...

CAMBRIDGE, Mass., Oct. 19, 2022 (GLOBE NEWSWIRE) — Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage biopharmaceutical company, focused on identifying, developing and commercializing treatments in high unmet need areas involving rare diseases and multi-drug resistant (MDR) bacterial infections, today announced data presentations for 7 abstracts accepted at the Infectious Disease Society of America (IDSA) IDWeek™ 2022, taking place from October 19 – 23, 2022 in Washington, DC. Spero-affiliated presentations will showcase clinical and nonclinical data for tebipenem HBr, Spero’s oral antibiotic investigational candidate in development for the treatment of adults with complicated urinary tract infection (cUTI), including pyelonephritis, along with health outcomes and epidemiologic data highlighting the potential...

NEW YORK, Oct. 19, 2022 (GLOBE NEWSWIRE) — StepStone Real Estate (SRE), the real estate arm of private markets investment firm StepStone Group (Nasdaq: STEP), announced today that Yasmine Uzmez has joined the firm as a Managing Director on its business development team. Ms. Uzmez will be based in StepStone’s New York office. Ms. Uzmez has more than 18 years’ experience in real estate and has held senior positions at real estate private placement firms Park Madison Partners and Shelter Rock Capital Advisors. In 2016, she founded Oderoche, a real estate capital raising and advisory boutique. A dual citizen of Belgium and the US, and a native French speaker, Ms. Uzmez began her career at J.P. Morgan in Belgium and Gemini Consulting in Paris and later joined CBRE’s consulting group in New York. “I have known Yasmine professionally...

Multitude SE – Managers’ Transactions – Vella ____________________________________________Person subject to the notification requirementName: Shaun VellaPosition: Other senior manager Issuer: Multitude SELEI: 74370078YLPFWHE33716Notification type: INITIAL NOTIFICATIONReference number: 20443/4/4____________________________________________ Transaction date: 2022-10-17Venue: XETRA – REGULIERTER MARKT (XETA)Instrument type: SHAREISIN: FI4000106299Nature of the transaction: ACQUISITION Transaction details(1): Volume: 1890 Unit price: 2.3802 EURAggregated transactions(1): Volume: 1890 Volume weighted average price: 2.3802 EUR

Announces Participation at Two Upcoming Investor Conferences TORONTO, Oct. 19, 2022 (GLOBE NEWSWIRE) — Altus Group Limited (ʺAltus” or “the Company”) (TSX: AIF), a market leading Intelligence as a Service provider to the global commercial real estate industry, announced today that it plans to release its third quarter financial results for the period ended September 30, 2022 after market close on Thursday, November 10, 2022. Altus Group executives Jim Hannon, Chief Executive Officer, and Angelo Bartolini, Chief Financial Officer, will host a conference call and webcast at 5:00 p.m. (ET) the same day to review the financial results and discuss corporate developments. Additionally, members of Altus’ executive leadership team are scheduled to participate in the following investor conferences in November:RBC Capital Markets Global...

MONTREAL, Oct. 19, 2022 (GLOBE NEWSWIRE) — Gildan Activewear Inc. (GIL: TSX and NYSE) will report its 2022 third quarter results on Thursday, November 3, 2022. A press release will be issued before markets open, and an audio webcast and conference call are scheduled on that same day at 8:30 AM ET to discuss the Company’s results. The live audio webcast of the conference call may be accessed via the investors section of Gildan’s corporate website at the following link Gildan Q3 2022 audio webcast. The conference call may be accessed by dialing (800) 715-9871 (Canada & U.S.) or (646) 307-1963 (international) and entering passcode 3908546. A replay of the conference call will be available for 7 days starting at 12:30 PM ET on Thursday, November 3, 2022, by dialing (800) 770-2030 (Canada & U.S.) or (609) 800-9909 (international)...

Multitude SE – Managers’ Transactions – Chatterjee ____________________________________________Person subject to the notification requirementName: Julie ChatterjeePosition: Other senior manager Issuer: Multitude SELEI: 74370078YLPFWHE33716Notification type: INITIAL NOTIFICATIONReference number: 20441/4/4____________________________________________ Transaction date: 2022-10-17Venue: XETRA – REGULIERTER MARKT (XETA)Instrument type: SHAREISIN: FI4000106299Nature of the transaction: ACQUISITION Transaction details(1): Volume: 3781 Unit price: 2.3802 EURAggregated transactions(1): Volume: 3781 Volume weighted average price: 2.3802 EUR

Multitude SE – Managers’ Transactions – Egger ____________________________________________Person subject to the notification requirementName: Bernd EggerPosition: Chief Financial Officer Issuer: Multitude SELEI: 74370078YLPFWHE33716Notification type: INITIAL NOTIFICATIONReference number: 20449/4/4____________________________________________ Transaction date: 2022-10-17Venue: XETRA – REGULIERTER MARKT (XETA)Instrument type: SHAREISIN: FI4000106299Nature of the transaction: ACQUISITION Transaction details(1): Volume: 4804 Unit price: 2.3802 EURAggregated transactions(1): Volume: 4804 Volume weighted average price: 2.3802 EUR